Amvac Ag
ZUG, Switzerland, June 18, 2010 - European patent EP 1272216B1 with the title "Vaccine consisting of
lactobacilli for the treatment of inflammation of the prostate and benign
prostatic hyperplasia" was granted by the European Patent Office on 9.6.2010.
ZUG, Switzerland, April 1, 2010 - The Swiss company AmVac AG, a biopharmaceutical company
located in Zug, has been granted a European patent (EP 1851 239 B1) for its
Sendai platform technology for its subsidiary company AmVac Research GmbH.
ZUG, Switzerland, December 3 - The Swiss biopharmaceuticals company AmVac AG in Zug has joined forces
with the long-term strategic investor V+ GmbH & Co Fonds 2 KG.
